{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T18:00:09Z","timestamp":1781978409780,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journalofclinicalvirology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jcv.2017.08.006","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T16:45:29Z","timestamp":1503074729000},"page":"36-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation"],"prefix":"10.1016","volume":"95","author":[{"given":"Radwan","family":"Massoud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basel","family":"Haffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Charafeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Kreidieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rami","family":"Mahfouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souha S.","family":"Kanj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"El Zakhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Kharfan-Dabaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Bazarbachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"El Cheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcv.2017.08.006_bib0005","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/sj.bmt.1705744","article-title":"Autotransplant conditioning regimens for aggressive lymphoma: are we on the right road?","volume":"40","author":"Fernandez","year":"2007","journal-title":"Bone Marrow Transpl."},{"issue":"21","key":"10.1016\/j.jcv.2017.08.006_bib0010","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1200\/JCO.2007.15.5358","article-title":"Impact of rituximab and\/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study","volume":"26","author":"Sebban","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"10","key":"10.1016\/j.jcv.2017.08.006_bib0015","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/sj.bmt.1703033","article-title":"Inverse relationship between human herpesvirus-6 and \u22127 detection after allogeneic and autologous stem cell transplantation","volume":"27","author":"Miyoshi","year":"2001","journal-title":"Bone Marrow Transpl."},{"issue":"6","key":"10.1016\/j.jcv.2017.08.006_bib0020","first-page":"1113","article-title":"Monitoring human herpesvirus-6 in patients with autologous stem cell transplantation","volume":"26","author":"Piukovics","year":"2014","journal-title":"In Vivo"},{"key":"10.1016\/j.jcv.2017.08.006_bib0025","unstructured":"L. Declerck, V. Queyrel, S. Morell-Dubois, A. Dewilde, H. Charlanne, D. Launay, et al., [Cytomegalovirus and systemic lupus: severe infection and difficult diagnosis]. La Revue de medecine interne\/fondee \u2026 par la Societe nationale francaise de medecine interne, 30(9) (2009) 789\u2013793. 10.1016\/j.revmed.2009.03.019."},{"key":"10.1016\/j.jcv.2017.08.006_bib0030","article-title":"Virus reactivations after autologous hematopoietic stem cell transplantation detected by multiplex PCR assay","author":"Inazawa","year":"2016","journal-title":"J. Med. Virol."},{"issue":"6","key":"10.1016\/j.jcv.2017.08.006_bib0035","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/tid.12309","article-title":"Evaluation of risk of symptomatic cytomegalovirus reactivation in myeloma patients treated with tandem autologous stem cell transplantation and novel agents: a single-institution study","volume":"16","author":"Marchesi","year":"2014","journal-title":"Transpl. Infect. Dis"},{"issue":"11","key":"10.1016\/j.jcv.2017.08.006_bib0040","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bmt.1704505","article-title":"Management of CMV infections: recommendations from the infectious diseases working party of the EBMT","volume":"33","author":"Ljungman","year":"2004","journal-title":"Bone Marrow Transpl."},{"issue":"2","key":"10.1016\/j.jcv.2017.08.006_bib0045","first-page":"88","article-title":"Preemptive ganciclovir administration based solely on asymptomatic pulmonary cytomegalovirus infection in allogeneic bone marrow transplant recipients: long-term follow-up","volume":"1","author":"Zaia","year":"1995","journal-title":"Biol. Blood Marrow Transpl."},{"issue":"2","key":"10.1016\/j.jcv.2017.08.006_bib0050","doi-asserted-by":"crossref","first-page":"ofw107","DOI":"10.1093\/ofid\/ofw107","article-title":"Efficacy and safety of a preemptive antiviral therapy strategy based on combined virological and immunological monitoring for active cytomegalovirus infection in allogeneic stem cell transplant recipients","volume":"3","author":"Navarro","year":"2016","journal-title":"Open Forum Infect. Dis."},{"issue":"5","key":"10.1016\/j.jcv.2017.08.006_bib0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/174.5.907","article-title":"Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation","volume":"174","author":"Boeckh","year":"1996","journal-title":"J. Infect. Dis."},{"issue":"12","key":"10.1016\/j.jcv.2017.08.006_bib0060","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood.V94.12.4029","article-title":"Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation","volume":"94","author":"Holmberg","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcv.2017.08.006_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/sj.bmt.1701827","article-title":"Cytomegalovirus viremia, viruria and disease after autologous peripheral blood stem cell transplantation: no need for surveillance","volume":"24","author":"Bilgrami","year":"1999","journal-title":"Bone Marrow Transpl."},{"issue":"8","key":"10.1016\/j.jcv.2017.08.006_bib0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bmt.1702877","article-title":"Cytomegalovirus pneumonia in adult autologous blood and marrow transplant recipients","volume":"27","author":"Konoplev","year":"2001","journal-title":"Bone Marrow Transpl."},{"issue":"1\u20132","key":"10.1016\/j.jcv.2017.08.006_bib0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0166-0934(01)00438-4","article-title":"Performance characteristics of an automated PCR assay for the quantification of cytomegalovirus DNA in plasma","volume":"101","author":"Preiser","year":"2002","journal-title":"J. Virol. Methods"},{"issue":"1","key":"10.1016\/j.jcv.2017.08.006_bib0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/cid\/ciw668","article-title":"Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials","volume":"64","author":"Ljungman","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.jcv.2017.08.006_bib0085","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1038\/bmt.2008.120","article-title":"CMV infections after hematopoietic stem cell transplantation","volume":"42","author":"Ljungman","year":"2008","journal-title":"Bone Marrow Transpl."},{"issue":"10","key":"10.1016\/j.jcv.2017.08.006_bib0090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bmt.1702033","article-title":"Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF","volume":"24","author":"Offidani","year":"1999","journal-title":"Bone Marrow Transpl."},{"issue":"1","key":"10.1016\/j.jcv.2017.08.006_bib0095","doi-asserted-by":"crossref","first-page":"e2015049","DOI":"10.4084\/mjhid.2015.049","article-title":"Cytomegalovirus reactivation in adult recipients of autologous stem cell transplantation: a single center experience","volume":"7","author":"Al-Rawi","year":"2015","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2017.08.006_bib0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jinf.2015.11.005","article-title":"Prospective surveillance vs clinically driven approach for CMV reactivation after autologous stem cell transplant","volume":"72","author":"Mengarelli","year":"2016","journal-title":"J. Infect."},{"issue":"3","key":"10.1016\/j.jcv.2017.08.006_bib0105","doi-asserted-by":"crossref","first-page":"129","DOI":"10.5500\/wjt.v5.i3.129","article-title":"Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: a single-center study","volume":"5","author":"Marchesi","year":"2015","journal-title":"World J. Transpl."},{"key":"10.1016\/j.jcv.2017.08.006_bib0110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/1471-2334-14-364","article-title":"The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage \u2013 a single center experience","volume":"14","author":"Nissen","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.jcv.2017.08.006_bib0115","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1182\/blood.V99.4.1486","article-title":"Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab","volume":"99","author":"Goldberg","year":"2002","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.jcv.2017.08.006_bib0120","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJM200109273451315","article-title":"Fatal reactivation of cytomegalovirus infection after use of rituximab for a post-transplantation lymphoproliferative disorder","volume":"345","author":"Suzan","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jcv.2017.08.006_bib0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00277-007-0397-0","article-title":"Rituximab therapy increased post-transplant cytomegalovirus complications in Non-Hodgkin's lymphoma patients receiving autologous hematopoietic stem cell transplantation","volume":"87","author":"Lee","year":"2008","journal-title":"Ann. Hematol."},{"issue":"8","key":"10.1016\/j.jcv.2017.08.006_bib0130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s00277-016-2700-4","article-title":"Cytomegalovirus infection in autologous stem cell transplant recipients in the era of rituximab","volume":"95","author":"Jain","year":"2016","journal-title":"Ann. Hematol."},{"issue":"1","key":"10.1016\/j.jcv.2017.08.006_bib0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/ejh.12551","article-title":"Cytomegalovirus reactivation in patients with multiple myeloma","volume":"96","author":"Hasegawa","year":"2016","journal-title":"Eur. J. Haematol."},{"issue":"1","key":"10.1016\/j.jcv.2017.08.006_bib0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2141.2001.02487.x","article-title":"Cytomegalovirus infection and non-neutropenic fever after autologous stem cell transplantation: high rates of reactivation in patients with multiple myeloma and lymphoma","volume":"112","author":"Fassas","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.jcv.2017.08.006_bib0145","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/tid.12449","article-title":"Cytomegalovirus reactivation after autologous stem cell transplantation in multiple myeloma patients treated with novel agents","volume":"17","author":"Naithani","year":"2015","journal-title":"Transpl. Infect. Dis."},{"issue":"1","key":"10.1016\/j.jcv.2017.08.006_bib0150","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/tid.12162","article-title":"High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network","volume":"16","author":"Marchesi","year":"2014","journal-title":"Transpl. Infect. Dis."},{"issue":"2","key":"10.1016\/j.jcv.2017.08.006_bib0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3816\/CLML.2010.n.019","article-title":"Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib","volume":"10","author":"Heider","year":"2010","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"2","key":"10.1016\/j.jcv.2017.08.006_bib0160","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2567.2007.02761.x","article-title":"Opelz G, et al. Proteasome inhibition suppresses essential immune functions of human CD4+ T cells","volume":"124","author":"Berges","year":"2008","journal-title":"Immunology"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217302238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653217302238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,15]],"date-time":"2020-10-15T16:13:45Z","timestamp":1602778425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653217302238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":32,"alternative-id":["S1386653217302238"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2017.08.006","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus reactivation in lymphoma and myeloma patients undergoing autologous peripheral blood stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2017.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}